Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular Basis of Synergistic Tau Amyloid Core Inhibition by K311/K353 Acetylation via Microsecond MD Simulations.

The journal of physical chemistry. B·2026

Same author

Electrodeposition of UO<sub>2</sub> at Mild Temperatures in Phosphonium Ionic Liquids: A Combined Theoretical and Experimental Study.

Langmuir : the ACS journal of surfaces and colloids·2026

Same author

Kirenol, a diterpene active component from Siegesbeckia orientalis, alleviates atopic dermatitis by suppressing TYK2.

International immunopharmacology·2026

Same author

Thiazolyl Blue as a High-Efficiency Leveler for Conformal Copper Electrodeposition in High-Aspect-Ratio PCB Through-Holes.

Langmuir : the ACS journal of surfaces and colloids·2026

Same author

β-sitosterol suppresses malignant biological behaviors and glycolysis via modulating YBX1-hnRNP K interaction in non-small cell lung cancer.

Scientific reports·2026

Same author

Semirational Engineering of α-Galactosidase for Improvement of Its Thermostability and Transglycosylation Ability.

Journal of agricultural and food chemistry·2026

Search research articles

Related Experiment Video

Updated: Jul 10, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

Immune-Cell-Based Therapy for COVID-19: Current Status.

Yiyuan Wang^1,2,3, Qinghe Liang^1,2,3, Fengsheng Chen^1,2,3

¹Laboratory of Anti-Inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, Southern Medical University, Guangzhou 510515, China.

|November 25, 2023

Summary

Cell therapy shows promise for treating COVID-19 by modulating immune responses. This review covers immune cells in COVID-19 pathogenesis and current cell therapy strategies.

Keywords:

COVID-19 SARS-CoV-2 cell therapy immunotherapy

More Related Videos

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

Related Experiment Videos

Last Updated: Jul 10, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

Area of Science:

Immunology
Infectious Diseases
Cell Therapy

Background:

COVID-19, caused by SARS-CoV-2, is a global pandemic.
Immune responses are critical in managing COVID-19.
Cell therapy is a novel approach to immune modulation.

Purpose of the Study:

To review immune cell subsets involved in COVID-19 pathogenesis.
To summarize the current status of cell therapy for COVID-19.

Main Methods:

Literature review of immune cell subsets in COVID-19.
Analysis of current cell therapy research and clinical trials for COVID-19.

Main Results:

Identified key immune cell subsets contributing to COVID-19.
Detailed the landscape of ongoing cell therapy research for COVID-19.

Conclusions:

Cell therapy offers a customizable and regenerative approach to COVID-19 treatment.
Further research is needed to optimize cell therapy strategies for COVID-19.